http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2144376-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2194ba29992b7108f0f59cb11bca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aace82384b679d8b90e9a5422f0e1059 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 1999-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a064cf3a002c036e7a4e970af5e9dbf0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce7a56f4bd15e0a1d53827d88c028b84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2b8b67d4264978001188b55b590f70e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9227375f239558ebaba50664a94927a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c32eaefe889ca60c555c81084622e408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d4d51dbb8f2a3ac96bfe65ef0dd325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_874df2c08170e5df8a361e0b55ebde20 |
| publicationDate | 2000-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2144376-C1 |
| titleOfInvention | Dry virus-vaccine against mareck's disease and method of its preparing |
| abstract | FIELD: veterinary virology, biotechnology. SUBSTANCE: invention relates to vaccine used for prophylaxis of Mareck's disease. Virus-vaccine has cell-free strain "VNIIZZH/N 110-DEP" (collection of VGNKI) of turkey herpes virus and protective medium. Vaccine has, wt.-%: strain VGNKI N "VNIIZZH/N 110" 40-60 and protective medium - the rest. Sucrose 8-% solution in phosphate buffer is used as the protective medium. Chicken embryo cultured fibroblast cells are used as cellular substrate. Strain VGNKI N "VNIIZZH/N 110" of turkey herpes virus is used at its biological activity 2 x 10 5 FOE focus-formig units/cm 3 . not less. Infected cellular mass is mixed with protective medium and disintegrated by ultrasonic treatment to obtain cell-free viruses. Vaccine is frozen and dried by lyophilization method. EFFECT: enhanced immunogenic activity of vaccine. 9 cl, 6 tbl, 1 dwg, 5 ex |
| priorityDate | 1999-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.